Jeff Cohen

Ladenburg Thalmann

Image: Jeff Cohen

Jeffrey Cohen, director, equity research with Ladenburg Thalmann & Co. Inc., has more than 20 years of professional experience in the worldwide financial markets, working with such companies as Cantor Fitzgerald, the American Stock Exchange (NYSE Euronext) and Sanwa Bank. For the past 13 years, Cohen has been actively involved in direct research, analysis and marketing pertaining to the growing $2.7T U.S. healthcare sector, including detailed fundamental and financial analysis specific to the development, marketing, delivery and commercialization of medical technologies, therapeutics and various other healthcare solutions. During the past seven years, Cohen has developed, published and presented detailed fundamental analytical reports and financial models for more than 34 publicly traded and privately held medical technology, healthcare service and biotechnology companies with more than $14B in aggregate market capitalization. Cohen is an engineer by early training and education (BSE University of Pennsylvania), including several years of experience planning, designing and implementing complex fixed-rail automated transportation systems. He also holds a master's degree in business administration and various FINRA licenses.

Recent Articles

Medical Device Co. Completes Merger in Q1/23 06/08/2023

Due to the acquisition, the U.S.-based firm generated 844% more revenue during the quarter than it did a year earlier, noted a Ladenburg Thalmann report.

Recent Quotes

"VIVE expanded the commercial sales force in Q1/18 to a total of 42."

— Jeff Cohen, Ladenburg Thalmann (5/11/18)
more >

Due to permission requirements, not all quotes are shown.